Corporate News Report
Charles River Laboratories (CRL)
Trading Activity
Shares rose 5.14 % during the 24‑hour period ending 01:07 AM Central Europe on Thursday, 22 October 2026.
Current trading price: USD 344.87 per share.
Shares traded in the last 24 hours: USD 401.7 million.
Market capitalization: USD 14.3 billion.
Shares outstanding: 47.7 million.
Historical Context
Since the close of the previous month, the stock has increased 13.06 %.
200‑day simple moving average: USD 216.16.
52‑week high: USD 333.30 (10 June 2026).
52‑week low: USD 146.20 (19 May 2026).
Related Stock Performance (Past 24 Hours)
Tractor Supply (TSCO): +0.3 % at USD 32.66; market cap USD 17.1 billion; P/E 17.14.
Ball (BALL): +0.5 % at USD 64.15; market cap USD 16.9 billion; P/E 18.20.
Fair Isaac (FICO): +2.39 % at USD 795.21; market cap USD 16.9 billion; P/E 22.70.
Tpg Inc (TPG): +2.97 % at USD 44.08; market cap USD 16.6 billion; P/E 83.92.
Revvity (RVTY): +3.36 % at USD 156.68; market cap USD 16.8 billion; P/E 72.88.
Company Overview
Charles River Laboratories International, Inc. is headquartered in Wilmington, United States. The firm operates within the health‑care sector, providing research tools and support services that facilitate drug discovery and development. Its core offerings include animal research models for pharmaceuticals, devices, and therapies. The company serves pharmaceutical and biotechnology firms, hospitals, and academic institutions worldwide. Charles River Laboratories is listed on the New York Stock Exchange, and its initial public offering was on 23 June 2000. For further details, visit the company’s website at www.criver.com .
